Spots Global Cancer Trial Database for cibisatamab
Every month we try and update this database with for cibisatamab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma | NCT03866239 | Colorectal Canc... | Obinutuzumab Atezolizumab Cibisatamab Tocilizumab | 18 Years - | Hoffmann-La Roche | |
A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma | NCT03866239 | Colorectal Canc... | Obinutuzumab Atezolizumab Cibisatamab Tocilizumab | 18 Years - | Hoffmann-La Roche | |
Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment | NCT04826003 | Metastatic Colo... | RO7122290 Cibisatamab Obinutuzumab | 18 Years - | Hoffmann-La Roche | |
A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma | NCT03866239 | Colorectal Canc... | Obinutuzumab Atezolizumab Cibisatamab Tocilizumab | 18 Years - | Hoffmann-La Roche |